Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 4, 2007, Pages 491-496

  Szepietowski, J C ^a   Reich, A ^a   Pacan, P ^a   Garlowska, E ^b   Baran, E ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Novartis Pharma   (Poland)

Author keywords

Fungal infections; Nails; Onychomycosis; Quality of life

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EDUCATION; EMOTION; FEMALE; FINGERNAIL ONYCHOMYCOSIS; FUNGUS CULTURE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PATIENT CODING; POLAND; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL ASPECT; TOENAIL ONYCHOMYCOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIFUNGAL AGENTS; ATTITUDE TO HEALTH; EDUCATIONAL STATUS; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; ONYCHOMYCOSIS; POLAND; QUALITY OF LIFE; RESIDENCE CHARACTERISTICS; RURAL HEALTH; SEX FACTORS; SOCIAL ADJUSTMENT; TIME FACTORS; URBAN HEALTH;

EID: 33947433134     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.02004.x     Document Type: Article

References (23)

1. Baran R, Dawber RPR. Diseases of the Nails and Their Management. Blackwell Science, Oxford, 1994.
2. Sikora M, Pacholek T, Soter K, Szepietowski J. Analysis of fungal skin and skin appendages infections in the region of Wroclaw in the years 1995-99. Mikol Lek 2000; 7: 145-151.
3. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey. Br J Dermatol 1992; 126: 23-37.
4. Heikkala H, Stubbs S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-701.
5. Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada - a multicenter survey of 2001 patients. Int J Dermatol 1997; 36: 783-787.
6. Roberts DT. Onychomycosis: Current treatment and future challenges. Br J Dermatol 1999; 141: 1-4.
7. Szepietowski JC. Selected clinical aspects of onychomycosis. Mikol Lek 2004; 11: 119-128.
8. Scher RK. Onychomycosis is more than a cosmetic problem. Br J Dermatol 1994; 130: 15.
9. Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J. Quality of life of persons with onychomycosis. Qual Life Res 1993; 2: 341-348.
10. Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997; 36: 754-756.
11. Whittam LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exp Dermatol 1997; 22: 87-89.
12. Drake LA, Scher RK, Smith EB et al. Effect of onychomycosis on quality of life. J Am Acad Dermatol 1998; 38: 702-704.
13. Drake LA, Patrick DL, Fleckman P et al. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999; 41: 189-196.
14. Lubeck DP, Gause D, Schein JR, Prebil LE, Potter LP. A health-related quality-of-life measure for use in patients with onychomycosis: A validation study. Qual Life Res 1999; 8: 121-129.
15. Millikan LE, Powell DW, Drake LA. Quality of life for patients with onychomycosis. Int J Dermatol 1999; 38: 13-16.
16. Turner RR, Testa MA. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res 2000; 9: 39-53.
17. Shaw JW, Joish VN, Coons SJ. Onychomycosis: Health-related quality of life considerations. Pharmacoeconomics 2002; 20: 23-36.
18. Szepietowski J, Salomon J, Finlay AY et al. Dermatology Life Quality Index (DLQI): Development of the Polish version. Dermatol Klin 2004; 6: 63-70.
19. Szepietowski JC, Polgrabio-Szwedo K, Reich A, Pacan P, Baran E. Polish version of the International Onychomycosis-specific Questionnaire. Mikol Lek 2007; 14, in press.
20. Drake L. Quality of life issues for patients with fungal nail infections. AIDS Patient Care 1995; 9: S15-S17.
21. Lubeck DP. Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol 1998; 38: S64-S68.
22. Kowalczuk-Zieleniec E, Nowicki E, Majkowicz M. Onychomycosis changes quality of life. J Eur Acad Dermatol Venerol 2002; 16: 248 (P23-20).
23. Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J Dermatolog Treat 2003; 14: 95-98.